Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arteriogenesis: lessons learned from clinical trials.

Dmitri Baklanov1, Michael Simons

  • 1Angiogenesis Research Center and the Section of Cardiology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA.

Endothelium : Journal of Endothelial Cell Research
|December 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Remote Patient Monitoring with Care Utilization in Patients with Chronic Cardiopulmonary Conditions.

Studies in health technology and informatics·2026
Same author

Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury.

Circulation research·2026
Same author

TWIST1 drives endothelial-to-mesenchymal-transition to stabilize atherosclerotic plaques.

Nature communications·2026
Same author

Retraction Note: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis.

Nature communications·2026
Same author

A fibroblast-like endothelial cell state promotes atherosclerosis via C/EBPβ-activated TGF-β signaling.

The EMBO journal·2026

Therapeutic angiogenesis promotes bypass blood vessels to restore blood flow in atherosclerotic disease. Lessons from Phase II trials inform growth factor delivery and duration for effective treatment strategies.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Arteriogenesis is the natural formation of bypass blood vessels that restore blood flow in occlusive vascular disease.
  • Therapeutic angiogenesis aims to promote this process for treating conditions like atherosclerotic disease.
  • Early clinical trials have provided valuable safety and formulation data for growth factor-based therapies.

Purpose of the Study:

  • To review and synthesize key findings from Phase II clinical trials focused on arteriogenesis.
  • To identify critical lessons learned regarding growth factor delivery, formulation, and treatment duration.
  • To inform future therapeutic strategies for promoting blood vessel formation.

Main Methods:

  • Review of double-blind, randomized Phase II clinical trials on arteriogenesis.

Related Experiment Videos

  • Analysis of data concerning human safety, growth factor formulation, and delivery methods.
  • Evaluation of treatment duration considerations in therapeutic angiogenesis.

    • Main Results:

    • Phase II trials have yielded substantial human safety data for therapeutic angiogenesis.
    • Key considerations for growth factor formulation, delivery, and duration of action have been identified.
    • Understanding of molecular regulation of blood vessel formation in adults is advancing.

    Conclusions:

    • Arteriogenesis-based therapies hold promise for treating occlusive atherosclerotic disease.
    • Lessons from Phase II trials are crucial for optimizing future clinical development.
    • Further research is needed to fully elucidate the molecular mechanisms and clinical applications of therapeutic angiogenesis.